Eli Lilly to buy gene therapy company Akouos for $487 mln | Reuters
Translation of Potential Genetic Medicines for the Inner Ear February 24, 2021 Michelle D. Valero
Hearing Health – Akouos
STEM Completes Lab Fit-Out for Akouos | High-Profile Monthly
Akouos - TRIA
Lilly Continues Foray into Gene Therapies with $487M Akouos Buyout | BioSpace
About Us – Akouos
Our Focus – Akouos
Lilly nabs another gene therapy firm, buying hearing loss player Akouos | pharmaphorum
Our Focus – Akouos
Akouos Receives FDA Clearance of its IND Application for Gene Therapy Hearing Loss Treatment, AK-OTOF | Hearing Health & Technology Matters
Lilly's message is loud and clear: Akouos' AAV hearing loss therapy is worthwhile | BioWorld
Akouos AK-OTOF Receives Positive Statement From EMA For ODD
Akouos nabs meaty $105M raise, adds VC and biotech veterans to board | Fierce Biotech
Akouos Just Raised $50 Million in a Series a Funding Round
Akouos (AKUS) Surges on $610M Buyout Deal With Eli Lilly
Akouos – Our Mission: Healthy Hearing Available to All
Working at Akouos – Akouos
Akouos shows efficacy with gene therapy for hearing loss — MedWatch
Luk H. Vandenberghe on LinkedIn: Congratulations to the Akouos team on the closing of one chapter in the…
Lilly snaps up hearing loss gene therapy player Akouos for $487M
Akouos (AKUS) Investor Presentation - Slidehsow (NYSE:LLY) | Seeking Alpha
g235629.jpg
Mission Statement, Vision, & Core Values (2024) of Akouos, Inc. (AKUS)
Akouos Announces Gene Therapy to Treat Genetic Hearing Loss | The Hearing Review
NEA on X: "🎉 Congratulations, Akouos! 👏🏽🤩🚀 Akouos to be acquired by @LillyPad: https://t.co/3qKl9lN3Wo https://t.co/UPMY69oh82" / X
Akouos doubles competitor's raise with $213M IPO - Boston Business Journal
